Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,900,946
+$2,262,870 QoQ
Shares Held
220,664
+51.6% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 245 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. DYN ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in DYN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,900,946 | 220,664 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,638,076 | 145,509 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,891,574 | 147,831 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,102,080 | 87,121 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $539,831 | 56,705 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $420,052 | 40,158 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $913,044 | 38,754 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $900,765 | 25,077 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $919,657 | 26,060 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $566,579 | 19,957 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $173,285 | 13,029 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $315,804 | 35,246 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $408,555 | 36,316 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $67,356 | 5,847 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $520 | 41 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,445 | 356 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,235 | 1,373 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $143,214 | 12,045 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $6,795 | 323 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $78,410 | 5,049 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $155,169 | 7,389 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||